Academic Activism: Choosing the Right Time and The Right Place - King/Lavizzo Lecture
Objectives and Disclosures
- Assess the clinical history of improved survival of children and adults with sickle cell disease in the current era
- Analyze the current success and failures for durative treatment of children and adults with sickle cell disease
- Outline clinical and genetic strategies to improve health outcomes before and after curative therapy in children and adults with sickle cell disease
Planners and speaker disclose they have no relevant financial relationships.
Michael DeBaun, MD, MPH
Professor of Pediatrics and Medicine, Vice Chair for Clinical and Translational Research, J.C. Peterson Chair in Pediatric Pulmonology, and Director, Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease
Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.
Seattle Children’s designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Videos are available for only one year after posting.
If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.